PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
12-Sep-2022 Establishment Labs Announces Hani Zeini has Joined the Company as Exclusive Advisor in Anticipation of US Launch Businesswire
12-Sep-2022 Horizon Therapeutics plc Announces Phase 2 Trial Evaluating Dazodalibep for the Treatment of Sjögren’s Syndrome Meets Primary Endpoint Businesswire
12-Sep-2022 Meaghan Hafner Appointed to Vice President, Health Care Businesswire
12-Sep-2022 Introducing Wellful Inc.: Nutrisystem and Adaptive Health Announce New Parent Company Name Businesswire
12-Sep-2022 Agomab Therapeutics Selected as One of Fierce Biotech's "Fierce 15" Companies of 2022 Businesswire
12-Sep-2022 Global White Oil Market Analysis Report 2022-2028: Extensive Industrialization in Emerging Economies & Elevating Demand as Adhesive in Food Packaging - ResearchAndMarkets.com Businesswire
12-Sep-2022 Spotlight Therapeutics Appoints Nallakkan Arvindan, Ph.D., MBA, as EVP and Chief Technology Officer Businesswire
12-Sep-2022 Hygieia adds clinical partners in New York and North Carolina to its d-Nav® Insulin Management Program Businesswire
12-Sep-2022 L’étude de phase III évaluant trifluridine/tipiracil en association au bevacizumab chez des patients ayant un cancer colorectal métastatique réfractaire a atteint son objectif principal d’amélioration de survie globale Businesswire
12-Sep-2022 Drug Combination Meets Survival Endpoint in Phase III Pivotal Trial Involving Participants With Refractory Metastatic Colorectal Cancer Businesswire
12-Sep-2022 Can-Fite: New Phase III Psoriasis Data Showing Superior Safety & Improved Efficacy Presented by KOL Dr. Papp at the 31st European Academy of Dermatology Businesswire
12-Sep-2022 Nimbus Therapeutics Closes $125M Private Financing to Advance Clinical Programs in Autoimmune Diseases and Oncology Businesswire
12-Sep-2022 ANI Pharmaceuticals Appoints Krista Davis as Chief Human Resources Officer Businesswire
12-Sep-2022 NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin to Showcase DERMAdoctor’s Eczema Balm on Return QVC® Appearance Businesswire
12-Sep-2022 TherapeuticsMD Appoints Dr. Brian Bernick and Mr. Mark Glickman as Interim Co-Chief Executive Officers Businesswire
12-Sep-2022 Cellics Therapeutics Announces Appointment of Paul Daruwala as President and CEO Businesswire
12-Sep-2022 KCAS Expands Its Transatlantic Presence with the Acquisition of France-based Active Biomarkers Businesswire
12-Sep-2022 Trinité-Sur-Mer Celebrates the Launch of the Class40 IBSA Businesswire
12-Sep-2022 Pretzel Therapeutics Launches With $72.5 Million Series A Financing to Pioneer Mitochondrial Therapies Businesswire
12-Sep-2022 SQZ Biotechnologies Presents Preclinical SQZ® TIL Data Supporting Potential Ability of mRNA-Driven IL-2 and IL-12 Expression to Eliminate Need for Toxic Preconditioning and Systemic IL-2 Administration for Certain T Cell Therapies Businesswire